Mometasone Furoate

CAS 83919-23-7 24 current records 1 historicalSmall Molecule

Who holds supplier records for Mometasone Furoate? 24 organisations hold a current record for Mometasone Furoate: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 21 of them hold a valid EU Certificate of Suitability (22 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (7), Italy (4), Israel (2), China (2) and 4 other countries (4); not recorded for 5.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Mometasone Furoate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/mometasone-furoate

Reading the evidence

  • 24 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 12 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Mometasone Furoate expires 24 Nov 2034. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (24)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Mometasone Furoate. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • AARTI PHARMALABS LIMITED
    Active DMF 21334, 27956, 33174 +1 · latest filing Sept 2018
    IndiaCEP
  • CORAL DRUGS PVT LTD
    Active DMF 30852, 31076, 35686 · latest filing Jul 2021
    IndiaCEP Company GMP cert on record
  • STERLING SPA
    Active DMF 27022, 16648, 44490 · latest filing Jul 2026
    ItalyCEP Company GMP cert on record
  • BREATHGREEN PHARMACEUTICAL CO LTD
    Active DMF 39302, 39303 · latest filing Dec 2023
    CEP
  • Cipla Limited
    Active DMF 20969, 41355, 27244 · latest filing Mar 2025
    IndiaCEP Company GMP cert on record
  • Farmabios S.p.A.
    Active DMF 22319, 33446 · latest filing Mar 2019
    ItalyCEP Company GMP cert on record
  • NEWCHEM SPA
    Active DMF 42344, 21993 · latest filing Oct 2025
    ItalyCEP Company GMP cert on record
  • SYMBIOTEC PHARMALAB PRIVATE LTD
    Active DMF 20684, 19781, 25448 · latest filing Oct 2011
    IndiaCEP Company GMP cert on record
  • WAVELENGTH ENTERPRISES LTD
    Active DMF 15187, 23888 · latest filing Jun 2010
    IsraelCEP Company GMP cert on record
  • SHANDONG RISEN-SUN PHARMACEUTICAL CO LTD
    Active DMF 44204, 44205 · latest filing May 2026
  • TIANJIN TIANYAO PHARMACEUTICALS CO LTD
    Active DMF 31362, 34112 · latest filing Dec 2019
    China
  • Aurisco Pharmaceutical Co.,ltd
    Active DMF 21141 · latest filing Dec 2007
    ChinaCEP Company GMP cert on record
  • CURIA SPAIN SAU
    Active DMF 23916 · latest filing Jun 2010
    SpainCEP Company GMP cert on record
  • HENAN LIHUA PHARMACEUTICAL CO LTD
    Active DMF 36182 · latest filing Nov 2021
    CEP
  • Hovione FarmaCiencia SA
    Active DMF 25987 · latest filing Apr 2012
    PortugalCEP Company GMP cert on record
  • INDUSTRIALE CHIMICA SRL
    Active DMF 35009 · latest filing Jul 2020
    ItalyCEP Company GMP cert on record
  • SYMBIOTICA SPECIALITY INGREDIENTS SDN BHD
    Active DMF 26153 · latest filing Jun 2012
    MalaysiaCEP
  • TAPI NL BV
    Active DMF 15063 · latest filing Sept 2000
    NetherlandsCEP
  • Taro Pharmaceutical Industries Ltd.
    Active DMF 23502 · latest filing May 2010
    IsraelCEP Company GMP cert on record
  • HALCYON LABS PRIVATE LTD
    Active DMF 21654 · latest filing May 2008
    India
  • SHAKTI LIFESCIENCE PRIVATE LIMITED
    IndiaCEP
  • SHANDONG SIRUI PHARMACEUTICAL CO LTD
    CEP
  • ZHEJIANG XIANJU PHARMACEUTICAL CO LTD
    CEP
  • AVIK PHARMACEUTICAL LIMITED
    Valid CEP holder (EDQM); not necessarily the manufacturer
    IndiaCEP
Need Mometasone Furoate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (22)

Certificates of Suitability on the EDQM register for Mometasone Furoate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 39 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD. TaizhouCN
CEP 2026-174 - Rev 00
Mometasone furoate monohydrate, Micronised
Sept 2026—
INDUSTRIALE CHIMICA S.R.L. SaronnoIT
CEP 2019-268 - Rev 01
Mometasone furoate
Sept 2026Inspected Oct 2025
Italy
TARO PHARMACEUTICAL INDUSTRIES, LTD. HaifaIL
CEP 2010-349 - Rev 04
Mometasone furoate, Micronised
Jul 2026Inspected Feb 2025
Israel
SYMBIOTEC PHARMALAB LIMITED IndoreIN
CEP 2007-194 - Rev 05
Mometasone furoate, Micronised
Apr 2026Inspected Mar 2026
Germany
STERLING S.p.A. CorcianoIT
CEP 2025-557 - Rev 00
Mometasone furoate monohydrate, Micronised
Mar 2026Inspected Dec 2025
Italy
BREATHGREEN PHARMACEUTICAL CO. LTD. ZaozhuangCN
CEP 2025-357 - Rev 00
Mometasone furoate monohydrate, Micronised and non-micronised
Feb 2026—
NEWCHEM S.p.A. MilanoIT
CEP 2024-348 - Rev 01
Mometasone furoate monohydrate, Crystalline Form, micronised
Oct 2025—
SHANDONG SIRUI PHARMACEUTICAL CO., LTD. HezeCN
CEP 2024-044 - Rev 00
Mometasone furoate
Jun 2025—
CIPLA LIMITED MumbaiIN
CEP 2018-290 - Rev 02
Mometasone furoate monohydrate, Micronised
Jun 2025—
WAVELENGTH ENTERPRISES LTD. Petah TikvaIL
CEP 2021-233 - Rev 02
Mometasone furoate monohydrate
May 2025—
AURISCO PHARMACEUTICAL CO., LTD. TiantaiCN
CEP 2008-094 - Rev 05
Mometasone furoate
Apr 2025Inspected Dec 2023
Germany
AARTI PHARMALABS LIMITED Mulund (W), MumbaiIN
CEP 2018-303 - Rev 03
Mometasone furoate monohydrate, Micronised
Mar 2025—
FARMABIOS S.p.A Gropello CairoliIT
CEP 2018-297 - Rev 04
Mometasone furoate, Micronised, alternative process
Mar 2025Inspected Jul 2026
Italy
TAPI NL B.V. AmsterdamNL
CEP 2022-287 - Rev 02
Mometasone furoate monohydrate
Mar 2025—
HENAN LIHUA PHARMACEUTICAL CO., LTD. AnyangCN
CEP 2024-339 - Rev 00
Mometasone furoate
Feb 2025—
CORAL DRUGS PRIVATE LIMITED New DelhiIN
CEP 2024-282 - Rev 00
Mometasone furoate monohydrate, Micronised
Oct 2024—
SHAKTI LIFESCIENCE PRIVATE LIMITED MumbaiIN
CEP 2023-269 - Rev 00
Mometasone furoate monohydrate
Sept 2024—
HOVIONE FARMACIENCIA S.A. LouresPT
CEP 2018-121 - Rev 03
Mometasone furoate monohydrate, Process I
Oct 2023Inspected Apr 2025
Portugal
AVIK PHARMACEUTICAL LIMITED VapiIN
R1-CEP 2008-221 - Rev 03
Mometasone furoate
Jun 2022—
SYMBIOTICA SPECIALITY INGREDIENTS SDN. BHD. ButterworthMY
R0-CEP 2021-006 - Rev 00
Mometasone furoate monohydrate
Feb 2022—
CURIA SPAIN S.A.U. BoecilloES
R1-CEP 2005-163 - Rev 02
Mometasone furoate
Aug 2021—
SYMBIOTICA SPECIALITY INGREDIENTS SDN. BHD. PeraiMY
R1-CEP 2009-313 - Rev 01
Mometasone furoate
Oct 2018—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (1)

Organisations whose Type II DMFs for Mometasone Furoate are no longer active. These show a past filing, not current supply.

Show all 1 historical record
  • HUNAN YUXIN PHARMACEUTICAL CO LTD
    Inactive DMF 25958 · filed Mar 2012

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (21 listed products contain Mometasone Furoate). The latest listed patent expires 24 Nov 2034. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Mometasone Furoate is a synthetic corticosteroid with anti-inflammatory and antipruritic properties. It is commonly used in the treatment of skin conditions and allergic rhinitis.

Chemical identity

IUPAC name
[(8S,9R,10S,11S,13S,14S,16R,17R)-9-chloro-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate
Canonical SMILES
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CCl)OC(=O)C5=CC=CO5)C)O)Cl)C
InChIKey
WOFMFGQZHJDGCX-ZULDAHANSA-N
Synonyms
Nasonex API, asmanex, dulera component mometasone furoate, elocon, lyr-210, lyr210, mometasone furoate anhydrous, nsc-746171, nsc-760077, sch 32088, sch-32088, sinuva

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Corticosteroid
Mechanism of action
Corticosteroid Hormone Receptor Agonists

Therapeutic areas

DermatologyRespiratory System

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Mometasone Furoate?

24 organisations hold an active US FDA Type II Drug Master File or a CEP for Mometasone Furoate: AARTI PHARMALABS LIMITED (India), CORAL DRUGS PVT LTD (India), STERLING SPA (Italy), BREATHGREEN PHARMACEUTICAL CO LTD, Cipla Limited (India), Farmabios S.p.A. (Italy), NEWCHEM SPA (Italy) and SYMBIOTEC PHARMALAB PRIVATE LTD (India), and 16 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Mometasone Furoate Drug Master Files are active?

AARTI PHARMALABS LIMITED (DMF 21334, 27956), CORAL DRUGS PVT LTD (DMF 30852, 31076), STERLING SPA (DMF 27022, 16648), BREATHGREEN PHARMACEUTICAL CO LTD (DMF 39302, 39303), Cipla Limited (DMF 20969, 41355), Farmabios S.p.A. (DMF 22319, 33446), NEWCHEM SPA (DMF 42344, 21993) and SYMBIOTEC PHARMALAB PRIVATE LTD (DMF 20684, 19781) and 12 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Mometasone Furoate records mean?

1 organisation has only inactive Type II DMFs for Mometasone Furoate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Mometasone Furoate have a European Certificate of Suitability?

Yes. 21 organisations hold a valid CEP for Mometasone Furoate on the EDQM register, including ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD. Taizhou (CN), INDUSTRIALE CHIMICA S.R.L. Saronno (IT), TARO PHARMACEUTICAL INDUSTRIES, LTD. Haifa (IL), SYMBIOTEC PHARMALAB LIMITED Indore (IN), STERLING S.p.A. Corciano (IT) and BREATHGREEN PHARMACEUTICAL CO. LTD. Zaozhuang (CN) and 16 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Mometasone Furoate?

Yes. The latest patent listed for an approved US product containing Mometasone Furoate expires 24 Nov 2034, across 21 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Mometasone Furoate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Mometasone Furoate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.